Teton Advisors, Inc. Neogenomics Inc Transaction History

Teton Advisors, Inc.

$212 Million
Q3 2024

A detailed history of Teton Advisors, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Teton Advisors, Inc. holds 55,100 shares of NEO stock, worth $782,971. This represents 0.38% of its overall portfolio holdings.

Number of Shares

55,100

Previous 55,500 0.72%

Holding current value

$782,971

Previous $769,000 5.59%

% of portfolio

0.38%

Previous 0.34%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$13.4 - $17.73 $5,360 - $7,092	-400 Reduced 0.72%	55,100 $812,000
Q1 2024 May 14, 2024	SELL	$14.06 - $16.79 $70,300 - $83,950	-5,000 Reduced 8.26%	55,500 $872,000
Q4 2021 Feb 11, 2022	SELL	$30.49 - $48.49 $30,490 - $48,490	-1,000 Reduced 1.63%	60,500 $2.06 Million
Q1 2021 May 14, 2021	SELL	$41.56 - $59.88 $240,216 - $346,106	-5,780 Reduced 8.59%	61,500 $2.97 Million
Q4 2020 Feb 05, 2021	SELL	$36.08 - $56.47 $36,080 - $56,470	-1,000 Reduced 1.46%	67,280 $3.62 Million
Q3 2020 Nov 06, 2020	SELL	$33.26 - $40.48 $756,265 - $920,434	-22,738 Reduced 24.98%	68,280 $2.52 Million
Q2 2020 Aug 13, 2020	SELL	$24.21 - $31.02 $454,228 - $581,997	-18,762 Reduced 17.09%	91,018 $2.82 Million
Q2 2019 Aug 02, 2019	SELL	$19.57 - $24.1 $97,850 - $120,500	-5,000 Reduced 4.36%	109,780 $2.41 Million
Q1 2019 May 02, 2019	SELL	$12.14 - $20.46 $344,484 - $580,572	-28,376 Reduced 19.82%	114,780 $2.35 Million
Q4 2018 Jan 30, 2019	SELL	$11.24 - $18.5 $592,584 - $975,338	-52,721 Reduced 26.92%	143,156 $1.81 Million
Q2 2018 Aug 10, 2018	SELL	$7.99 - $14.05 $12,224 - $21,496	-1,530 Reduced 0.78%	195,877 $2.57 Million
Q3 2017 Nov 01, 2017	BUY	$9.11 - $11.26 $1.8 Million - $2.22 Million	197,407	197,407 $2.2 Million

Others Institutions Holding NEO

# of Institutions

291

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.79B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teton Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Teton Advisors, Inc. with notifications on news.

Account

Teton Advisors, Inc. Neogenomics Inc Transaction History